Literature DB >> 15928953

[Molecular pathogenesis of cervical cancer and its first steps].

M J Trunk1, N Wentzensen, M von Knebel Doeberitz.   

Abstract

Specific types of the human papillomaviruses (high risk human papillomaviruses) play an essential role in the pathogenesis of cervical cancer. Although infections by these viruses are very common in the general population, only few result in clinically relevant lesions. Continuous and deregulated expression of two viral oncoproteins E6 and E7 in basal or parabasal cells are required to induce and maintain neoplastic growth. In the course of an acute HPV-infection these genes are exclusively expressed in cell cycle arrested, terminally differentiated cells in the intermediate or superficial layers of the epithelium. Accidental activation of these genes in proliferating cells in the basal or parabasal cell layers results in interference with the cell cycle regulation, disturbances of the mitotic spindle apparatus and centrosome functions. This results in numerical and structural chromosome aberrations, chromosomal instability, increasing aneuploidy and initiates cervical carcinogenesis. The deregulated expression of the viral oncogene E7 is indicated by strong over-expression of the cellular p16(INK4a) gene product. This finding may have significant influence on novel strategies in cervical cancer diagnosis and screening. This review summarizes the basic molecular mechanisms of how papillomaviruses contribute to cellular transformation and how this can influence future diagnostic applications.

Entities:  

Mesh:

Year:  2005        PMID: 15928953     DOI: 10.1007/s00292-005-0763-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  34 in total

Review 1.  Epidemiology of genital human papillomavirus infection.

Authors:  L Koutsky
Journal:  Am J Med       Date:  1997-05-05       Impact factor: 4.965

2.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

3.  The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.

Authors:  Ming Guo; Lulin Hu; Mithra Baliga; Z He; Michael D Hughson
Journal:  Am J Clin Pathol       Date:  2004-12       Impact factor: 2.493

4.  alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP.

Authors:  C S Yoon; K D Kim; S N Park; S W Cheong
Journal:  Biochem Biophys Res Commun       Date:  2001-05-11       Impact factor: 3.575

5.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

Review 6.  Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract.

Authors:  Nicolas Wentzensen; Svetlana Vinokurova; Magnus von Knebel Doeberitz
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

7.  Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.

Authors:  Tomomi Yoshida; Toshio Fukuda; Takaaki Sano; Tatsuya Kanuma; Nobuo Owada; Takashi Nakajima
Journal:  Cancer       Date:  2004-04-25       Impact factor: 6.860

Review 8.  Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.

Authors:  Stefan Duensing; Karl Münger
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

9.  The natural history of type-specific human papillomavirus infections in female university students.

Authors:  Harriet Richardson; Gail Kelsall; Pierre Tellier; Hélène Voyer; Michal Abrahamowicz; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-06       Impact factor: 4.254

10.  Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.

Authors:  Sophia S Wang; Marcus Trunk; Mark Schiffman; Rolando Herrero; Mark E Sherman; Robert D Burk; Allan Hildesheim; M Concepcion Bratti; Tom Wright; Ana Cecilia Rodriguez; Sabrina Chen; Anja Reichert; Christina von Knebel Doeberitz; Ruediger Ridder; Magnus von Knebel Doeberitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-08       Impact factor: 4.254

View more
  5 in total

1.  GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer.

Authors:  Beray Kiran; Mutlu Karkucak; Hakan Ozan; Tahsin Yakut; Kemal Ozerkan; Sebnem Sag; Mehmet Ture
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

Review 2.  [HPV-associated squamous cell carcinogenesis].

Authors:  G Assmann; K Sotlar
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

Review 3.  [Precancerous lesions of the uterine cervix: morphology and molecular pathology].

Authors:  L-C Horn; K Klostermann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 4.  Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

Authors:  J P A Baak; A-J Kruse; S J Robboy; E A M Janssen; B van Diermen; I Skaland
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

5.  [Immunocytochemistry of p16(INK4a) and Ki-67 as adjunctive method for routine gynecological cytology of mild and moderate dysplasia].

Authors:  P Ziemke; K Marquardt
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.